129 related articles for article (PubMed ID: 30683829)
1. Cysteinyl leukotrienes predominantly mediate cisplatin-induced acute renal damage in male rats.
Hashim AA; Helmy MM; Mouneir SM
J Physiol Pharmacol; 2018 Oct; 69(5):. PubMed ID: 30683829
[TBL] [Abstract][Full Text] [Related]
2. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity.
Alkhamees OA; Alroujayee AS; Abuohashish HM; Alrojayee FS; Ahmed MM
Cancer Chemother Pharmacol; 2017 Jul; 80(1):55-64. PubMed ID: 28502039
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats.
Gad AM; El-Raouf OMA; El-Sayeh BM; Fawzy HM; Abdallah DM
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28902463
[TBL] [Abstract][Full Text] [Related]
5. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
6. Enhanced lipoxygenase/LTD4 signaling accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats.
Helmy MW; Helmy MM; El-Mas MM
Biomed Pharmacother; 2018 Jun; 102():309-316. PubMed ID: 29571015
[TBL] [Abstract][Full Text] [Related]
7. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
8. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats.
Hagar H; Medany AE; Salam R; Medany GE; Nayal OA
Exp Toxicol Pathol; 2015 Feb; 67(2):133-41. PubMed ID: 25488130
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
10. Zileuton alleviates acute cisplatin nephrotoxicity: Inhibition of lipoxygenase pathway favorably modulates the renal oxidative/inflammatory/caspase-3 axis.
Helmy MM; Hashim AA; Mouneir SM
Prostaglandins Other Lipid Mediat; 2018 Mar; 135():1-10. PubMed ID: 29355720
[TBL] [Abstract][Full Text] [Related]
11. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
Helmy MM; El-Gowelli HM
Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.
Sherif IO
Clin Exp Nephrol; 2015 Aug; 19(4):591-7. PubMed ID: 25389052
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor antagonism alleviates renal injury induced by ischemia-reperfusion in rats.
Hagar HH; Abd El Tawab R
J Surg Res; 2012 Nov; 178(1):e25-34. PubMed ID: 22487384
[TBL] [Abstract][Full Text] [Related]
14. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
15. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.
Steib CJ; Bilzer M; op den Winkel M; Pfeiler S; Hartmann AC; Hennenberg M; Göke B; Gerbes AL
Hepatology; 2010 Jun; 51(6):2086-96. PubMed ID: 20512996
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced renal toxicity via tumor necrosis factor-α, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng.
Yousef MI; Hussien HM
Food Chem Toxicol; 2015 Apr; 78():17-25. PubMed ID: 25640527
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
Holma R; Salmenperä P; Riutta A; Virtanen I; Korpela R; Vapaatalo H
Eur J Pharmacol; 2001 Oct; 429(1-3):309-18. PubMed ID: 11698051
[TBL] [Abstract][Full Text] [Related]
18. Cough, asthma, and cysteinyl-leukotrienes.
Niimi A
Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
[TBL] [Abstract][Full Text] [Related]
19. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
20. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats.
Borrego A; Zamora ZB; González R; Romay C; Menéndez S; Hernández F; Montero T; Rojas E
Mediators Inflamm; 2004 Feb; 13(1):13-9. PubMed ID: 15203559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
